IRIS UniCatt

Ferrandina, Maria Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.420
AS - Asia 10.969
EU - Europa 10.498
SA - Sud America 2.051
AF - Africa 297
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 26
AN - Antartide 1
Totale 37.289
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.073
SG - Singapore 5.143
DE - Germania 2.847
CN - Cina 2.527
SE - Svezia 1.761
BR - Brasile 1.698
IT - Italia 1.365
FR - Francia 1.005
VN - Vietnam 1.004
UA - Ucraina 715
PL - Polonia 679
IN - India 539
IE - Irlanda 512
GB - Regno Unito 494
ID - Indonesia 326
FI - Finlandia 311
RU - Federazione Russa 272
HK - Hong Kong 258
JP - Giappone 240
BD - Bangladesh 191
CA - Canada 169
TR - Turchia 152
AR - Argentina 132
IQ - Iraq 101
NL - Olanda 100
MX - Messico 98
BE - Belgio 75
ZA - Sudafrica 72
AT - Austria 62
ES - Italia 62
PK - Pakistan 62
CI - Costa d'Avorio 54
EC - Ecuador 52
SA - Arabia Saudita 46
IR - Iran 43
LT - Lituania 42
KR - Corea 40
MA - Marocco 40
VE - Venezuela 37
PY - Paraguay 34
UZ - Uzbekistan 33
CL - Cile 32
KE - Kenya 32
CZ - Repubblica Ceca 31
JO - Giordania 31
CO - Colombia 30
EG - Egitto 27
RO - Romania 25
AE - Emirati Arabi Uniti 24
PH - Filippine 24
CH - Svizzera 21
IL - Israele 21
AU - Australia 19
MY - Malesia 18
TN - Tunisia 18
EU - Europa 16
BH - Bahrain 15
DZ - Algeria 14
JM - Giamaica 14
PE - Perù 14
UY - Uruguay 14
AZ - Azerbaigian 13
NP - Nepal 13
PA - Panama 13
AL - Albania 12
DO - Repubblica Dominicana 12
GR - Grecia 12
KZ - Kazakistan 12
LB - Libano 12
HR - Croazia 11
OM - Oman 11
SN - Senegal 11
HU - Ungheria 10
KG - Kirghizistan 10
MD - Moldavia 10
ET - Etiopia 9
LV - Lettonia 9
HN - Honduras 8
PS - Palestinian Territory 8
PT - Portogallo 8
TW - Taiwan 8
BO - Bolivia 7
CR - Costa Rica 7
RS - Serbia 7
TT - Trinidad e Tobago 7
AM - Armenia 6
BG - Bulgaria 6
GE - Georgia 6
MT - Malta 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
AO - Angola 5
NI - Nicaragua 5
XK - ???statistics.table.value.countryCode.XK??? 5
DK - Danimarca 4
MN - Mongolia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
TJ - Tagikistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
Totale 37.220
Salva come PNG Salva come JPEG
Città #
Singapore 2.826
Chandler 1.875
San Jose 1.368
Ashburn 1.216
Warsaw 608
Beijing 565
Dublin 497
Jacksonville 441
San Mateo 408
New York 357
Ho Chi Minh City 348
Wilmington 312
Jakarta 301
Lauterbourg 275
Nanjing 268
Los Angeles 265
Rome 265
Hanoi 251
Hangzhou 242
Hong Kong 227
Ann Arbor 223
Tokyo 208
Houston 207
The Dalles 195
Boston 186
Frankfurt am Main 185
Dearborn 178
Hyderabad 176
Hefei 171
Milan 164
Fairfield 156
Dallas 155
São Paulo 150
Nürnberg 149
Moscow 148
Woodbridge 143
Princeton 138
Cattolica 137
Munich 134
Seattle 131
Marseille 126
Lawrence 122
Helsinki 107
Redwood City 105
Chicago 93
Santa Clara 93
Buffalo 90
Bremen 84
Nanchang 83
Council Bluffs 79
Boardman 77
Izmir 74
Brussels 69
Da Nang 66
Orem 63
Cambridge 62
London 62
Leawood 60
St Louis 59
Zhengzhou 59
Lancaster 57
Atlanta 55
Abidjan 54
University Park 54
Brooklyn 53
Strasbourg 53
Mountain View 52
Shanghai 51
Toronto 49
Kraków 47
Norwalk 47
Detroit 46
Kunming 46
Belo Horizonte 45
Changsha 43
Düsseldorf 43
Haiphong 43
Paris 43
Turku 43
Hebei 42
Johannesburg 42
Rio de Janeiro 42
Chennai 41
Kent 41
Nuremberg 41
Redmond 41
Shenyang 41
Denver 40
Guangzhou 40
Jiaxing 39
Amsterdam 38
Augusta 37
Montreal 36
Seoul 35
Vienna 34
Baghdad 33
San Francisco 33
Tianjin 33
Dhaka 32
Phoenix 32
Totale 19.599
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 866
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer 522
Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study 402
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 376
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial 360
Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence 316
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients 310
Evaluation of quality of life and emotional distress in endometrial cancer patients: A 2-year prospective, longitudinal study 239
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results 234
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 231
I nuovi mezzi di contrasto nello studio delle patologie ginecologiche. Applicazioni diagnostiche e prospettive terapeutiche. 230
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series 229
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 227
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 226
Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer. 223
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 198
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer. 197
Adrenomedullin in Ovarian Cancer: Foe In Vitro and Friend In Vivo? 196
Role of minimally invasive surgery versus open approach in patients with early-stage uterine carcinosarcomas: a retrospective multicentric study 194
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 191
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 190
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 189
Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging. 185
Prognostic role of Ca125 response criteria and RECIST criteria: analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer. 184
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 183
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 182
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 181
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? 179
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 177
Ultrasound contrast examination to discriminate benign and malignant adnexal masses 176
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 176
Sonographic imaging of urinoma 175
Neuroendocrine stress response in patients undergoing benign ovarian cyst surgery by laparoscopy, minilaparotomy, and laparotomy 174
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 174
Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia) 174
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. 173
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 173
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 171
A case of isolated ovarian recurrence from vulvar carcinoma. 170
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 169
Imaging in gynecological disease (1): ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumor 168
Ultrasound evaluation of intra-abdominal sites of disease to predict the likelihood of suboptimal cytoreduction in advanced ovarian cancer: a propective study 168
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 167
Malignant transformation of Madelung's disease in a patient with a coincidental diagnosis of breast cancer: a case report. 165
Preoperative local-regional staging of endometrial cancer: transvaginal sonography versus magnetic resonance imaging 164
Color Doppler sonographic features of a Krukenberg tumor in pregnancy 164
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 164
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 164
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 162
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study 160
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes 160
Uterine inversion in association with uterine sarcoma: a case report with MRI findings and review of the literature 158
Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial 157
Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: the experience at Gemelli hospital and a literature review 156
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients 155
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 155
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 154
Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial 153
Female pelvis 152
Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: a dose-escalation study. 151
Epidermal growth factor levels in human breast cyst fluid 150
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 150
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 150
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery 149
Minimally invasive salvage lymphadenectomy in gynecological cancer patients: A single institution series 149
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study 148
Robotic Surgery in Elderly and Very Elderly Gynecologic Cancer Patients 147
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital 147
The 'lead vessel': a vascular ultrasound feature of metastasis in the ovaries. 146
MRI in uterine cancers with uncertain origin: Endometrial or cervical? Radiological point of view with review of the literature 143
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? 142
Prognostic Significance of Ultrasound Characteristics and Body Mass Index in Patients with Apparent Early-Stage Cervical Cancer: A Single-Center, Retrospective, Cohort Study 142
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 142
Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis 142
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 141
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 141
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer 141
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 140
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery 139
Receptors for epidermal growth factor and steroid hormones in primary colorectal tumors 139
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 139
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 139
EROS study: Evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis 138
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 138
Multidisciplinary Tumor Board Smart Virtual Assistant in Locally Advanced Cervical Cancer: A Proof of Concept 138
Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy 138
Real-world management of trabectedin/pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian cancer patients: A national survey 137
How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study 137
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study 136
Ultrasound and color power Doppler in the detection of metastatic omentum: a prospective study 136
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 136
Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients. 136
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 136
Arterial-enteric fistula after pelvic lymphadenectomy in secondary cytoreductive surgery for recurrent ovarian cancer 136
The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer 135
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases 135
Outcomes of High-Grade Cervical Dysplasia with Positive Margins and HPV Persistence after Cervical Conization 134
Successful multimodal treatment of a breast cancer patient with a recurrence invading the chest wall 134
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 134
Clinical Impact of Pathologic Residual Tumor in Locally Advanced Cervical Cancer Patients Managed by Chemoradiotherapy Followed by Radical Surgery: A Large, Multicenter, Retrospective Study 134
Totale 18.333
Salva come PNG Salva come JPEG
Categoria #
all - tutte 156.841
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.841
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202191 0 0 0 0 0 0 0 0 0 0 0 91
2021/20222.576 283 157 47 255 121 64 46 407 108 192 387 509
2022/20235.153 689 708 409 780 339 628 223 384 624 138 153 78
2023/20242.461 100 725 67 157 73 319 178 87 47 96 313 299
2024/20255.404 134 135 387 186 481 177 226 244 827 661 1.037 909
2025/202613.847 2.081 393 822 1.517 2.316 819 2.438 765 955 1.003 474 264
Totale 38.678